Brib.Bo
BRIB.BO operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and commercial customers.
Business. BRIB.BO operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and commercial customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
BRIB.BO operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and commercial customers.
BRIB.BO has a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing, and a current ratio of 1.13, suggesting limited short-term liquidity cushion. The company's free cash flow of INR 74.58 million reflects its ability to generate cash after capital expenditures, though the negative net cash position after subtracting total debt raises concerns about liquidity risk.
The company's return on equity (ROE) of 11.12% and return on assets (ROA) of 3.68% are below the typical thresholds for capital-intensive chemical firms, which often aim for ROE above 15% and ROA above 5%. This suggests that BRIB.BO is underperforming in terms of capital efficiency and asset utilization relative to industry norms.
BRIB.BO's revenue is concentrated in a single business segment, as disclosed in its latest financials, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic downturns and regulatory shifts, particularly in the chemical manufacturing sector.
The company's revenue growth is not explicitly provided in the latest financials, but the operating income of INR 180.60 million and net income of INR 84.93 million suggest a stable but modest performance. The capital expenditure of INR -110.35 million indicates a reduction in investment, which may signal a strategic shift or financial constraint.
BRIB.BO faces medium liquidity risk due to its current ratio of 1.13 and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution events reported in the latest filings. However, the company's reliance on debt financing and limited free cash flow could increase dilution pressure in the future.
No recent events or filings are disclosed in the available data, which limits the ability to assess the company's response to market conditions or strategic initiatives.
- BRIB.BO has a moderate debt-to-equity ratio but faces liquidity concerns due to a low current ratio and negative net cash position.
- The company's ROE and ROA are below industry benchmarks, indicating suboptimal capital and asset efficiency.
- Revenue is concentrated in a single segment with no geographic diversification, increasing exposure to regional risks.
- Capital expenditures have declined, suggesting a potential strategic shift or financial constraint.
- The company faces medium liquidity risk and low dilution risk, but its financial structure could become more vulnerable in a downturn.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- BRIB.BO Market data — financials · 2026-05-27